Pharmaceutical Executive
Pharmaceutical Executive
Pharmaceutical Executive Podcast
Recent Licensing Agreement Poised to Advance Company ADC
22 minutes Posted Jan 26, 2024 at 5:25 pm.
0:00
22:51
Download MP3
Show notes
Jingsong Wang, Chairman of Nona Biosciences, discusses Nona Biosciences’ recent exclusive license agreement with Pfizer Inc. for the development and commercialization of HBM9033, an innovative antibody-drug conjugate (ADC) targeting MSLN, a key antigen in various solid tumors. Wang believes that the partnership will significantly advance Nona's Harbour Mice® platform and ADC ecosystem.